Person: ŞENTÜRK, HAKAN
72 results
Search Results
Now showing 1 - 10 of 72
Publication Metadata only Role of Serum and Biliary CEA, CA19-9, VEGFR-3 and TAC for Differentation of Malignant and Benign Biliary Obstruction(2014-05-01) Ince, ALİ TÜZÜN; YILDIZ, Kemal; BAYSAL, Birol; DANALIOGLU, Ahmet; KOCAMAN, Orhan; TOZLU, Mukaddes; GANGARAPU, Venkatanarayana; KEMIK, Ahu Sarbay; UYSAL, Oemer; Senturk, HAKAN; İNCE, ALİ TÜZÜN; UYSAL, ÖMER; ŞENTÜRK, HAKANPublication Metadata only Sa1359 – Cholecystitis in Pancreatic Carcinoma: A Poorly Recognized Condition with High Rate of Sepsis Related Mortality Cholecystitis in Pancreatic Carcinoma: A Poorly Recognized Condition with High Rate of Sepsis Related Mortality.(2019-05-28T00:00:00Z) Koçhan, Koray; ŞENTÜRK, HAKAN; KÖKER, İBRAHİM HAKKI; BİBERCİ KESKİN, ELMAS; İNCE, ALİ TÜZÜN; BAŞARANOĞLU, METİN; ŞENTÜRK, HAKAN; KÖKER, İBRAHİM HAKKI; KOÇHAN, KORAY; BİBERCİ KESKİN, ELMAS; İNCE, ALİ TÜZÜN; BAŞARANOĞLU, METİNPublication Metadata only Pankreas Adenokarsinomu ve Tümör Çevresi Pankreas Doku Örneklerinde Helicobacter Pylori Sesifik DNA Varlığının Araştırılması 12 Ulusal Hepato Gastroenteroloji Kongresi Afyon(2015-10-11T00:00:00Z) BAYSAL, BİROL; Gültepe, B; İNCE, ALİ TÜZÜN; Gültepe, İ; KAYAR, YUSUF; Erdem, Emrullah; BAŞARANOĞLU, METİN; DANALIOĞLU, AHMET; ŞENTÜRK, HAKAN; İNCE, ALİ TÜZÜN; BAŞARANOĞLU, METİN; ŞENTÜRK, HAKANPublication Metadata only The evaluation of cellular and humoral immunity characteristics in gastrointestinal and hepatocellular cancers(2014-06-25T00:00:00Z) TÜRKDOĞAN, MEHMET KÜRŞAT; KIZILTAN, HÜRİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; KAYAR, YUSUF; ŞENTÜRK, HAKAN; İNCE, ALİ TÜZÜN; KOCAMAN, ORHAN; Danalıoğlu, Ahmed; KIZILTAN, HURİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; ŞENTÜRK, HAKAN; İNCE, ALİ TÜZÜNPublication Metadata only Preliminary Results of Pigtail Plastic Stent (PPS) and Fully Covered Self Expandable Metallic Stent (FCSEMS) Placement in the Endoscopic Treatment of Pancreatic Fluid Collections(2013-05-01T00:00:00Z) Senturk, Hakan; Kocaman, Orhan; Baysal, Birol; Ince, ALİ TÜZÜN; Danalioglu, Ahmet; Tozlu, Mukaddes; Kocakoc, Ercan; ŞENTÜRK, HAKAN; İNCE, ALİ TÜZÜNPublication Metadata only A randomized controlled trial of home monitoring versus hospitalization for mild non-alcoholic acute interstitial pancreatitis: A pilot study(2014-05-01) Ince, ALİ TÜZÜN; Senturk, HAKAN; Singh, Vikesh K.; YILDIZ, Kemal; DANALIOGLU, Ahmet; CINAR, Ahmet; Uysal, Omer; KOCAMAN, Orhan; BAYSAL, Birol; Guerakar, Ahmet; İNCE, ALİ TÜZÜN; ŞENTÜRK, HAKAN; UYSAL, ÖMERBackground/Objectives: Acute pancreatitis (AP) is a disease typically requiring in-hospital treatment. We conducted a trial to assess the feasibility of early discharge from the hospital for patients with mild nonalcoholic acute pancreatitis (NAAP).Publication Metadata only ID: 3524972 MUCINOUS PANCREATIC CYST SUBGROUPS: THE ROLE OF CYST FLUID VISCOSITY AND CYST MORPHOLOGY IN DIFFERENTIATION(2021-05-21T00:00:00Z) KÖKER, İBRAHİM HAKKI; Elagöz, Şahende; MALYA, FATMA ÜMİT; Kiremitçi, Sercan; İNCE, ALİ TÜZÜN; ŞENTÜRK, HAKAN; KÖKER, İBRAHİM HAKKI; MALYA, FATMA ÜMİT; İNCE, ALİ TÜZÜN; ŞENTÜRK, HAKANPublication Metadata only Efficacy of Rifaximin on Circulating Endotoxins and Cytokines in Patients With Non-Alcoholic Fatty Liver(2015-04-01) Gangarapu, Venkatanarayana; Ince, Ali T.; BAYSAL, Birol; KAYAR, Yusuf; Senturk, HAKAN; KILIC, Ulkan; GOK, Ozlem; Uysal, Oemer; İNCE, ALİ TÜZÜN; ŞENTÜRK, HAKAN; UYSAL, ÖMERPublication Metadata only Pankreas kistlerinde tersiyer merkez deneyimimiz(2018-10-14T00:00:00Z) koray, koçhan; KÖKER, İBRAHİM HAKKI; BİBERCİ KESKİN, ELMAS; ünver, nurcan; İNCE, ALİ TÜZÜN; ŞENTÜRK, HAKAN; KÖKER, İBRAHİM HAKKI; BİBERCİ KESKİN, ELMAS; KOÇHAN, KORAY; İNCE, ALİ TÜZÜN; ŞENTÜRK, HAKANPublication Open Access The relationship between serum histon levels and the severity of acute pancreatitis.(2019-09-01) Biberci, Keskin; Şentürk, H; Köker, İH; Sümbül, Gültepe; İnce, AT; İNCE, ALİ TÜZÜN; SÜMBÜL, BİLGE; ŞENTÜRK, HAKANBackground/Aims: Despite various scoring systems and imaging methods, it is hard to predict the severity and the course of acute pancreatitis (AP), thereby necessitating better and more reliable markers. Since inflammation plays a key role in the pathogenesis of AP, we sought to determine whether histone, which is a novel inflammatory marker, may play a role in the prediction of severity and prognosis. Materials and Methods: A total of 88 consecutive adult patients (>18 years) with a first AP episode were prospectively enrolled in the study. Severe AP was defined as having a revised Atlanta score >3 in the first 48 h after admission. Circulating histone 3 and 4 levels were measured using the enzyme-linked immunosorbent assay method. Results: Eighty-eight consecutive adult patients with a first episode of AP were divided into two groups according to severity, in which 56 (63.6%) were assigned to the mild AP group and 32 (36.4%) to the severe AP group. White blood cell, hemoglobin, creatinine, and aspartate aminotransferase levels were significantly higher in the severe AP group. However, there was no difference in serum histone levels between the groups, and there was no correlation between revised Atlanta score and serum histone levels either. Conclusion: Serum histone levels did not significantly differ between the severe and mild AP groups. Therefore, these markers may not provide additional benefit for determining the severity of AP.